We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+27.4%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$409M
AUM Growth
+$1.31M
(+0.32%)
Cap. Flow
-$55.4M
Cap. Flow
% of AUM
-13.56%
Top 10 Holdings %
Top 10 Hldgs %
9.96%
Holding
345
New
97
Increased
17
Reduced
117
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Upbound Group
UPBD
|
+$2.54M |
| 2 |
PRFT
Perficient Inc
PRFT
|
+$2.53M |
| 3 |
ARQL
Arqule Inc
ARQL
|
+$2.33M |
| 4 |
Goosehead Insurance
GSHD
|
+$2.32M |
| 5 |
CryoPort
CYRX
|
+$2.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEUM
Pareteum Corporation
TEUM
|
+$3.8M |
| 2 |
NVTA
Invitae Corporation
NVTA
|
+$3.69M |
| 3 |
Adeia
ADEA
|
+$3.05M |
| 4 |
American Superconductor
AMSC
|
+$3.05M |
| 5 |
Stride
LRN
|
+$2.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.79% |
| 2 | Technology | 25.64% |
| 3 | Industrials | 15.05% |
| 4 | Consumer Discretionary | 9.18% |
| 5 | Financials | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Lindblad Expeditions
LIND
$1.94B
| $1.49M | 0.36% |
83,059
| – | – |
|
|
ARNA
127
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.49M | 0.36% |
+25,356
| New | +$1.31M |
|
128
Q2 Holdings
QTWO
$3.8B
| $1.48M | 0.36% |
19,396
-4,214
| -18% | -$305K |
|
129
Wendy's
WEN
$1.4B
| $1.46M | 0.36% |
+74,697
| New | +$1.41M |
|
130
Coherus Oncology
CHRS
$217M
| $1.46M | 0.36% |
+66,041
| New | +$1.15M |
|
131
Materion
MTRN
$4.39B
| $1.45M | 0.35% |
+21,350
| New | +$1.34M |
|
132
Sinclair Inc
SBGI
$992M
| $1.45M | 0.35% |
+26,968
| New | +$1.37M |
|
133
Marchex
MCHX
$76.2M
| $1.44M | 0.35% |
306,826
-156,927
| -34% | -$750K |
|
134
Perdoceo Education
PRDO
$1.99B
| $1.44M | 0.35% |
+75,571
| New | +$1.39M |
|
135
DNA X Inc
SONM
$5.05M
| $1.44M | 0.35% |
+63
| New | +$1.6M |
|
136
Fate Therapeutics
FATE
$286M
| $1.44M | 0.35% |
70,799
| – | – |
|
137
Victory Capital Holdings
VCTR
$6.19B
| $1.44M | 0.35% |
83,608
| – | – |
|
138
Paylocity
PCTY
$7.38B
| $1.44M | 0.35% |
15,291
-4,120
| -21% | -$391K |
|
|
LHCG
139
DELISTED
LHC Group LLC
LHCG
| $1.39M | 0.34% |
11,650
-3,498
| -23% | -$394K |
|
|
SAFE
140
DELISTED
Safehold Inc.
SAFE
| $1.39M | 0.34% |
+46,136
| New | +$1.23M |
|
|
PRO
141
DELISTED
PROS Holdings
PRO
| $1.39M | 0.34% |
21,920
-15,229
| -41% | -$802K |
|
142
The Ensign Group
ENSG
$10.4B
| $1.37M | 0.33% |
25,717
-7,119
| -22% | -$356K |
|
143
Quanterix
QTRX
$164M
| $1.37M | 0.33% |
40,527
| – | – |
|
144
Universal Display
OLED
$3.68B
| $1.35M | 0.33% |
7,169
-3,641
| -34% | -$606K |
|
|
MNTV
145
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $1.34M | 0.33% |
81,209
-7,464
| -8% | -$128K |
|
146
Zscaler
ZS
$24.5B
| $1.31M | 0.32% |
17,110
-5,102
| -23% | -$363K |
|
147
CareTrust REIT
CTRE
$9.91B
| $1.3M | 0.32% |
54,859
-17,535
| -24% | -$425K |
|
|
CHCT
148
Community Healthcare Trust
CHCT
$523M
| $1.3M | 0.32% |
+32,995
| New | +$1.23M |
|
149
Guardant Health
GH
$21.7B
| $1.29M | 0.32% |
14,996
-1,380
| -8% | -$105K |
|
150
Planet Fitness
PLNT
$4.42B
| $1.28M | 0.31% |
17,690
-7,280
| -29% | -$549K |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2019 Portfolio in Review
As of Q2 2019, EAM Investors held 345 positions worth $409M, up 0.32% from $408M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
EAM Investors withdrew a net $55.4M in Q2 2019, closing 103 positions and reducing 117 holdings. Its most notable exit was Pareteum Corporation, an estimated $3.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 28% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Upbound Group worth $2.85M.
- EAM Investors's largest Q2 2019 buy was Upbound Group: 106,882 shares worth $2.85M.
- EAM Investors added most to Krystal Biotech in Q2 2019, an estimated $1.92M increase.
- EAM Investors's biggest Q2 2019 reduction was Codexis, cutting an estimated $2.65M.
- EAM Investors fully exited Pareteum Corporation in Q2 2019, selling an estimated $3.8M.
- EAM Investors's ten largest holdings make up 10% of its $409M portfolio in Q2 2019.
- EAM Investors opened 97 new positions and closed 103 in Q2 2019.
- EAM Investors's portfolio value rose 0.32% quarter-over-quarter to $409M.
Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.